I patologiske tilstande, hvor vævsfaktorer kan forventes at forekomme i højere grad end normalt, kan der være potentiel risiko for udvikling af tromboseepisoder eller induktion af dissemineret intravaskulær koagulation (DIC) i forbindelse med behandling med NovoSeven.
In pathological conditions in which tissue factor may be expressed more extensively than considered normal, there may be a potential risk of development of thrombotic events or induction of Disseminated Intravascular Coagulation (DIC) in association with NovoSeven treatment.